Series B - Cerevance
Investment Firm
Overview
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Announced Date
Apr 25, 2024
Closed on Date
Apr 25, 2024
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
6
Round Details and Background
Cerevance raised $47000000 on 2024-04-25 in Series B
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 13, 2023 |  Series B - Cerevance | 8 | - | 51.0M |
| Apr 25, 2024 | Series B - Cerevance | 8 | - | 47.0M |
| May 03, 2017 | Series A - Cerevance | 4 | - | 5.0M |
| Dec 02, 2016 | Series A - Cerevance | 2 | - | 21.5M |
Recent Activity
There is no recent news or activity for this profile.